Stock Events

Stock Events

Fennec Pharmaceuticals (FRX.TO) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.27

0

0.28

0.56

Details

Expected EPS

-0.0342675

Actual EPS

-0.27414

Surprise EPS

-0.24

Surprise Percent

+700%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of -0.27414 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.